Burkhart Erin's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Sep 23, 2026
- Accession no.
- 0001927648-26-000005
- Filed
- Sep 23, 2026, 4:17 PM ET
- Trade date
- Sep 22, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burkhart ErinCIK 0001927648 | Officer (SVP, Controllership) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Common Stock | MOption exerciseAcquired | +2,223 | –F1 | – | 2,223 | Direct | |
| Sep 22, 2026 | Common Stock | FTax withholdingDisposed | −768 | $152.67 | −$117,250.56 | 1,455 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Common Stock | MOption exerciseDisposed | −2,223 | –F1 | – | 9,022 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.